Medical journal-Oncotarget

Oncotarget is one of the international which since its creation has been primarily focusing on the necessary basis of all cancers, the development of cancer as well as the treatment of the diseases for the purpose of improving the lives of cancer patients. Oncotarget does not only focus on treatment of cancer and other medical conditions, but it also puts more efforts on the management of programs, therapeutics agents, and other procedures on the handling of the patients including satisfaction, adherence as well as quality life. The journal is of great benefit to both the patients and the medical experts as it assists them to have the knowledge of the new as well as the existing therapies regarding their outcome, how it improves the lives of the patients as well as how the treatment has been accepted by the medical professionals.

Oncotarget is recognized medical journal, and it is a member who has subscribed to the principles of the committee on publication ethics. The medical journal is published online in all media platforms, and it is free for quick research. Oncotarget is published by Impact Journals

One of the social media platforms which Oncotarget publishes it medical reports, as well as studies, is the Dove Press. Dove Medical Press was founded in December 2003 with a primary objective of find new and improved publishing technology as well as high-class editorial standards. Since the creation of Dove Medical Press, it has been expanding its services to other nations and Cities including Lon don and Manchester, the United Kingdom, Memphis and Tennessee, United States and Auckland, New Zealand where they have offices. The medical journal referred its medical papers and published research with impact factors which include

Therapeutics and clinical risk management (Journal impact factor 1.405)

Oncotarget and therapy (journal impact factor 2.073)

International Journal of COPD (Journal factor 3.141)

International journal of nanomedicine (journal impact factor 3.463)

Drug Design Development and Therapy (Journal impact factor 3.486)

Clinical Intervention in Aging (Journal Impact Factor 2.651)

Dove medical press is a privately owned organization with a primary responsibility of publishing journals in the medical sector focusing on science, technology, and medicine. Oncotarget is also available on Dove Press.

Leave a Reply

Your email address will not be published. Required fields are marked *